Literature DB >> 17220050

Effect of food on bioavailability of a single oral dose of clopidogrel in healthy male subjects.

Ramakrishna V S Nirogi1, Vishwottam N Kandikere, Koteshwara Mudigonda.   

Abstract

OBJECTIVE: The present study aimed at investigating the effects of concomitant food intake on the bioavailability of a single oral dose of clopidogrel (CAS 113665-84-2).
METHODS: Clopidogrel was given under two conditions separated by a 14-day washout period: fasted and fed (after a standardized high fat breakfast). Concentrations of clopidogrel in plasma were quantified by a validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) with positive ion electro-spray ionization using multiple reaction monitoring (MRM). Pharmacokinetic parameters such as Cmax, Tmax, AUC0-t, AUC0-inf and tl/2z were estimated using a noncompartmental model.
RESULTS: The pharmacokinetic parameters were significantly affected by food intake. Specifically, Cm, and AUC0-inf of clopidogrel increased 6.1-fold and 9.2-fold, respectively, in the fed condition compared to the fasted condition. The t1/2 increased from 2.5 h in the fasted state to 5.0 h in the fed state. The limit of quantification was 5 pg/mL for plasma clopidogrel analysis.
CONCLUSION: Food substantially enhanced the bioavallability of clopidogrel in healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17220050     DOI: 10.1055/s-0031-1296783

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  2 in total

1.  Adjusted indirect comparisons to assess bioequivalence between generic clopidogrel products in Serbia.

Authors:  Zorica Pejčić; Katarina Vučićević; Alfredo García-Arieta; Branislava Miljković
Journal:  Br J Clin Pharmacol       Date:  2019-07-07       Impact factor: 4.335

Review 2.  Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy.

Authors:  Zhi-Yu Wang; Meng Chen; Ling-Ling Zhu; Lu-Shan Yu; Su Zeng; Mei-Xiang Xiang; Quan Zhou
Journal:  Ther Clin Risk Manag       Date:  2015-03-19       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.